Medicare to Try a Blend of Hospice Care and Treatment – The New York Times

Randomized trials of patients with terminal cancer point to a new approach on palliative care, one that Medicare will test more widely.

Most older Americans close to death have to make a difficult choice: continue with traditional medical treatment or switch tohospice care, which focuses not on a cure but on easing their remaining days.

Now, Medicare is testing a third alternative: both.

The new pilot program, designed to affect the care of about 150,000 Medicare patients over the next four years, will allow patients with terminal diseases to receive hospice care to manage suffering and counseling to plan for the end of life — but still see doctors and get medical treatments, like chemotherapy or hospitalization, intended to fight their illnesses.

The test program is based on research that shows that patients with access to both so-called palliative care and traditional medicine often end up with a better quality of life and less expensive, intense medical treatment. The approach may even offer the patients a longer life span than those treated with traditional medicine alone.

That surprising result came from a type of study that is unusual in evaluating services for patients: a randomized controlled trial. Such trials, which randomly assign patients to get different sorts of care, are common for studying new drugs, but rare when it comes to health care policy. But they are becoming more popular, as The Upshot reported last year, because randomized trials can provide definitive, and counterintuitive, results.

The question of how to mix palliative care, intended to manage patients’ symptoms, and curative care to fight disease has been studied in three randomized trials of cancer patients. All showed benefits to the approach.

Dr. Jennifer Temel, an author of a randomized study of patients with lungcancer, said she was sometimes asked why such a trial was needed for an idea that seemed intuitive. But doctors are evidence oriented, she said, and the studies have provided a strong basis for changes in medical practice and payment policies from insurers like Medicare.

The speed with which cancer treatments are changing, for example, can lead to confusion. “It is harder for patients to decide that ‘I don’t want more chemotherapy,’ ” said Dr. Temel, clinical director of thoracic oncology at Massachusetts General Hospital. “I think we need more of a gray zone where patients can get the benefits of hospice care but still receive chemotherapy to help them live longer.”

The Medicare pilot program will itself be a kind of randomized trial. So many hospices wanted to participate in the program that Medicare was able to randomly select half to start the program in 2016 and the rest to start two years later. Comparing the outcomes between the two groups, and a third group of hospices that never applied, will allow for a more robust evaluation of whether the policy makes sense for all of Medicare, said Dr. Patrick Conway, the principal deputy administrator and chief medical officer at the Centers for Medicare and Medicaid Services.

“If it’s successful, and we think it will be, it’s a strong evidence base to potentially scale it to the entire Medicare population,” he said.

There are risks with the new approach. As reporting from The Washington Post has shown, hospice care is a part of Medicare where unscrupulous providers can commit fraud by signing up healthy patients for services. In cases in which patients will not have to sacrifice more traditional medical care, there is a risk that hospice providers may sign up patients who do not really want or need their services.

Dr. Conway said the pilot program would be set up to limit which patients would be eligible and to carefully monitor the providers for fraud.

Medicare will also monitor the cost of patients in the trial program and those who get the traditional medical benefit. The randomized trial will teach the government how to achieve the best health outcomes for dying patients. But it will also show which approach is more costly.

Source: Medicare to Try a Blend of Hospice Care and Treatment – The New York Times

%d bloggers like this: